Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Invested Capital (2021 - 2025)

Aytu Biopharma (AYTU) has disclosed Return on Invested Capital for 6 consecutive years, with 0.14% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Invested Capital rose 215.0% to 0.14% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.14%, a 215.0% increase, with the full-year FY2025 number at 0.11%, down 6.0% from a year prior.
  • Return on Invested Capital was 0.14% for Q4 2025 at Aytu Biopharma, down from 0.11% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.08% in Q3 2024 to a low of 2.28% in Q4 2024.
  • A 5-year average of 0.55% and a median of 0.26% in 2023 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: plummeted -212bps in 2024, then surged 215bps in 2025.
  • Aytu Biopharma's Return on Invested Capital stood at 0.55% in 2021, then crashed by -133bps to 1.28% in 2022, then surged by 87bps to 0.16% in 2023, then tumbled by -1296bps to 2.28% in 2024, then surged by 94bps to 0.14% in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Return on Invested Capital are 0.14% (Q4 2025), 0.11% (Q3 2025), and 0.09% (Q2 2025).